Background BPC-157 was initially synthesized in the early 1990s and studied for its cytoprotective properties as an anti-ulcer agent
Current areas of scientific investigation include cellular energy metabolism studies, mitochondrial signaling investigations, metabolic pathway coordination research, NAD pathway analysis, NNMT inhibitor research, and multi-compound metabolic signaling studies
They see the Clevenger case as something with implications far beyond a single D-III school
Timing matters significantly in animal models, as early administration following injury consistently produces stronger healing outcomes than delayed dosing
Different brands, flavours etc
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
